Gapping up
In reaction to strong earnings/guidance: TERP +1%, (releases prelim Q2 results with adj $152--160 mln and adj revs $198-206 mln)
M&A news:
In reaction to strong earnings/guidance: TERP +1%, (releases prelim Q2 results with adj $152--160 mln and adj revs $198-206 mln)
M&A news:
- ISLE +28.4% (to be acquired by Eldorado Resorts (ERI) for $23.00/share in cash or 1.638 shares of ERI stock)
- BLOX +15.3% (confirms it will be acquired by Vista Equity Partners for $26.50 per share in cash)
- TECD +7.1% (to acquire the Technology Solutions biz from Avnet (AVT))
- HMY +2.7% (Harmony Gold acquires full ownership of the Hidden Valley mine from Newcrest Mining (NCMGY) in New Guinea)
Select EU financial related names showing strength: BCS +2.4%, HSBC +1.9%, SAN +1.6%, ING +1.4%, .
Select metals/mining stocks trading higher: BHP +2.8%, PAAS +2.1%, AU +2%, SLV +1.9%, FCX +1.8%, SLW +1.6%,GOLD +1.5%, ABX +1.2%, .
Select oil/gas related names showing strength: SDRL +2.8%, CHK +2.3%, MRO +2.2%, BP +2%, RDS.A +1.8%, TOT+1.4%, .
Other news:
Select metals/mining stocks trading higher: BHP +2.8%, PAAS +2.1%, AU +2%, SLV +1.9%, FCX +1.8%, SLW +1.6%,GOLD +1.5%, ABX +1.2%, .
Select oil/gas related names showing strength: SDRL +2.8%, CHK +2.3%, MRO +2.2%, BP +2%, RDS.A +1.8%, TOT+1.4%, .
Other news:
- NBY +21.6% (announces that data from a Phase 2b clinical study with Auriclosene Irrigating Solution demonstrated statistically significant and clinically meaningful results in the prevention of urinary catheter blockage and encrustation)
- NVAX +8.5% (modestly rebounding following last week's declines)
- CFRX +4.8% (promotes Cara Cassino, MD to Chief Medical Officer and Executive VP of Research and Development effective Oct 1)
- GPRO +3.9% (ahead of new product launch event (including Karma drone))
- CLCD +2.8% (reports its SAMURAI achieves secondary endpoints)
- RDUS +2.3% (reports new positive results from the Phase 3 ACTIVE Trial of Abaloparatide published in JBMR)
Analyst comments:
- AKS +4.4% (upgraded to Sector Weight from Underweight at KeyBanc)
- X +2.8% (upgraded to Sector Weight from Underweight at KeyBanc)
- GM +2.7% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- KBH +2.2% (upgraded to Buy from Neutral at Buckingham Research)
- EPD +1.4% (upgraded to Outperform from Neutral at Credit Suisse)
- RBS +1.2% (upgraded to Hold from Sell at Investec)
- WFC +0.9% (upgraded to Outperform from Neutral at Robert W. Baird)
- TRGP +0.9% (upgraded to Buy from Neutral at Goldman)